Goldman Sachs’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-390
| Closed | -$8.24K | – | 5016 |
|
|
2023
Q2 | $8.24K | Sell |
390
-8,418
| -96% | -$178K | ﹤0.01% | 4809 |
|
|
2023
Q1 | $237K | Buy |
8,808
+3,121
| +55% | +$84K | ﹤0.01% | 4451 |
|
|
2022
Q4 | $201K | Sell |
5,687
-1,040
| -15% | -$36.8K | ﹤0.01% | 4503 |
|
|
2022
Q3 | $1.52M | Sell |
6,727
-1,839
| -21% | -$416K | ﹤0.01% | 3552 |
|
|
2022
Q2 | $1.62M | Sell |
8,566
-437
| -5% | -$82.6K | ﹤0.01% | 3602 |
|
|
2022
Q1 | $2.24M | Sell |
9,003
-3,819
| -30% | -$951K | ﹤0.01% | 3499 |
|
|
2021
Q4 | $2M | Buy |
12,822
+123
| +1% | +$19.2K | ﹤0.01% | 3500 |
|
|
2021
Q3 | $2.55M | Sell |
12,699
-1,154
| -8% | -$231K | ﹤0.01% | 3287 |
|
|
2021
Q2 | $3.54M | Sell |
13,853
-3,088
| -18% | -$789K | ﹤0.01% | 3050 |
|
|
2021
Q1 | $4.5M | Sell |
16,941
-1,307
| -7% | -$347K | ﹤0.01% | 2742 |
|
|
2020
Q4 | $6.73M | Buy |
18,248
+3,826
| +27% | +$1.41M | ﹤0.01% | 2298 |
|
|
2020
Q3 | $3.52M | Buy |
14,422
+4,574
| +46% | +$1.12M | ﹤0.01% | 2590 |
|
|
2020
Q2 | $2.84M | Buy |
9,848
+7,842
| +391% | +$2.26M | ﹤0.01% | 2658 |
|
|
2020
Q1 | $409K | Sell |
2,006
-1,590
| -44% | -$324K | ﹤0.01% | 3589 |
|
|
2019
Q4 | $1.61M | Buy |
3,596
+228
| +7% | +$102K | ﹤0.01% | 3052 |
|
|
2019
Q3 | $1.04M | Buy |
3,368
+2,282
| +210% | +$702K | ﹤0.01% | 3232 |
|
|
2019
Q2 | $345K | Sell |
1,086
-1,105
| -50% | -$351K | ﹤0.01% | 3671 |
|
|
2019
Q1 | $919K | Buy |
2,191
+737
| +51% | +$309K | ﹤0.01% | 3303 |
|
|
2018
Q4 | $443K | Buy |
1,454
+1,094
| +304% | +$333K | ﹤0.01% | 3451 |
|
|
2018
Q3 | $130K | Sell |
360
-103
| -22% | -$37.2K | ﹤0.01% | 3903 |
|
|
2018
Q2 | $169K | Buy |
463
+69
| +18% | +$25.2K | ﹤0.01% | 3915 |
|
|
2018
Q1 | $116K | Buy |
+394
| New | +$116K | ﹤0.01% | 3986 |
|
|
2017
Q3 | – | Sell |
-1,148
| Closed | -$272K | – | 4448 |
|
|
2017
Q2 | $272K | Buy |
+1,148
| New | +$272K | ﹤0.01% | 3848 |
|
|
2016
Q1 | – | Sell |
-91
| Closed | -$60K | – | 4643 |
|
|
2015
Q4 | $60K | Buy |
91
+3
| +3% | +$1.98K | ﹤0.01% | 4134 |
|
|
2015
Q3 | $42K | Sell |
88
-37
| -30% | -$17.7K | ﹤0.01% | 4368 |
|
|
2015
Q2 | $71K | Buy |
125
+88
| +238% | +$50K | ﹤0.01% | 4378 |
|
|
2015
Q1 | $319K | Buy |
37
+5
| +16% | +$43.1K | ﹤0.01% | 3598 |
|
|
2014
Q4 | $279K | Buy |
+32
| New | +$279K | ﹤0.01% | 3753 |
|
|
2014
Q3 | – | Sell |
-30
| Closed | -$219K | – | 4630 |
|
|
2014
Q2 | $219K | Sell |
30
-45
| -60% | -$329K | ﹤0.01% | 3920 |
|
|
2014
Q1 | $403K | Buy |
+75
| New | +$403K | ﹤0.01% | 3496 |
|